[go: up one dir, main page]

PL1993365T3 - Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem - Google Patents

Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem

Info

Publication number
PL1993365T3
PL1993365T3 PL07752521T PL07752521T PL1993365T3 PL 1993365 T3 PL1993365 T3 PL 1993365T3 PL 07752521 T PL07752521 T PL 07752521T PL 07752521 T PL07752521 T PL 07752521T PL 1993365 T3 PL1993365 T3 PL 1993365T3
Authority
PL
Poland
Prior art keywords
bioavailable
age
disease
related disorders
treating alzheimer
Prior art date
Application number
PL07752521T
Other languages
English (en)
Inventor
Sally A Frautschy
Greg M Cole
Original Assignee
Univ California
The U S Government Represented By The Dept Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, The U S Government Represented By The Dept Of Veterans Affairs filed Critical Univ California
Publication of PL1993365T3 publication Critical patent/PL1993365T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07752521T 2006-03-06 2007-03-06 Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem PL1993365T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77981706P 2006-03-06 2006-03-06
EP07752521.0A EP1993365B1 (en) 2006-03-06 2007-03-06 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
PCT/US2007/005829 WO2007103435A2 (en) 2006-03-06 2007-03-06 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders

Publications (1)

Publication Number Publication Date
PL1993365T3 true PL1993365T3 (pl) 2013-10-31

Family

ID=38475534

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07752521T PL1993365T3 (pl) 2006-03-06 2007-03-06 Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem

Country Status (5)

Country Link
US (1) US9192644B2 (pl)
EP (1) EP1993365B1 (pl)
ES (1) ES2427216T3 (pl)
PL (1) PL1993365T3 (pl)
WO (1) WO2007103435A2 (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2644093A1 (en) * 2006-03-17 2007-09-27 Herbalscience Singapore Pte. Ltd. Extracts and methods comprising curcuma species
CA2647348A1 (en) 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
JP2011527340A (ja) * 2008-07-07 2011-10-27 ライラ ファーマシューティカルズ ピーブイティ．エルティディ． 経口活性クルクミノイド化合物
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
JP5775462B2 (ja) * 2008-11-17 2015-09-09 ライラ ファーマシューティカルズ ピーブイティ．エルティディ． 眼疾患に適用するためのクルクミノイドおよびその代謝物
CA2746273C (en) * 2008-12-11 2019-04-09 Human Biomolecular Research Institute Small molecule immunomodulators for alzheimer's disease
EP2408442B1 (en) * 2009-03-20 2016-08-17 Bioxtract S.A. Pharmaceutical composition presenting anti-inflammatory properties
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
AU2011292760A1 (en) * 2010-08-18 2013-04-04 Clearfarma Industries Ltd. Functional food compositions and methods
ES2616022T3 (es) * 2010-09-15 2017-06-09 Cadila Pharmaceuticals Ltd. Composiciones farmacéuticas de curcumina
BR112013008737A2 (pt) * 2010-10-14 2015-09-01 Abbott Gmbh & Co Kg Formulação de dispersão sólida de curcuminóide
ES2718090T3 (es) 2010-11-08 2019-06-27 Cadila Pharmaceuticals Ltd Composición farmacéutica de taxoides
US8785380B2 (en) 2011-02-01 2014-07-22 M/S Akay Flavours & Aromatics Pvt Ltd. Formulation containing curcuminoids exhibiting enhanced bioavailability
CN103442703B (zh) 2011-05-16 2016-01-27 欧米尼艾克蒂夫健康技术有限公司 具有增强的生物利用度的含姜黄素的水溶性组合物及其方法
GB2507884B (en) 2011-06-03 2019-10-23 Signpath Pharma Inc Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
CN102274163B (zh) * 2011-08-12 2013-01-02 山东大学 一种姜黄素纳米胶束制剂及其制备方法
WO2013086330A1 (en) * 2011-12-08 2013-06-13 Abbott Laboratories Nutritional compositions comprising curcumin and docosahexaenoic acid for improving cognition
EP2804587B1 (en) * 2012-01-19 2019-05-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Formulation and method for increasing oral bioavailability of drugs
EP3666265A1 (en) * 2012-05-22 2020-06-17 Cave, Harold Gordon Improved complexes and compositions containing curcumin
JP2015522810A (ja) * 2012-06-14 2015-08-06 サインパス ファルマ, インク.Signpath Pharma, Inc. リポソームのクルクミン及びその代謝産物であるテトラヒドロクルクミンの薬物動態を測定するための方法及びシステム
AT515178A5 (de) * 2012-08-31 2015-07-15 Univ North Texas Curcumin-er, ein nanocurcumin aus liposomalem plga mit anhaltender freisetzung zur minimierung der qt-verlängerung zur krebstherapie
RU2494733C1 (ru) 2012-10-16 2013-10-10 Всеволод Иванович Киселев Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты)
TWI660680B (zh) 2012-11-26 2019-06-01 美商通路實業集團國際公司 抗氧化膳食增補劑及其相關方法
CN102949375B (zh) * 2012-11-28 2015-04-08 厦门大学附属第一医院 一种盐酸小檗碱固体脂质纳米制剂及其制备方法
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
US20160287533A1 (en) * 2013-11-27 2016-10-06 Research Foundation Of The City University Of New York Activity Enhancing Curcumin Compositions and Methods of Use
CA2933204C (en) 2013-12-18 2020-04-28 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
CN103784421B (zh) * 2014-02-27 2016-04-27 哈尔滨医科大学 载姜黄素和胡椒碱的固体脂质纳米粒及其制备方法
CA2950758C (en) 2014-06-03 2020-04-28 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies
WO2015186144A2 (en) * 2014-06-07 2015-12-10 Laila Pharmaceuticals Pvt. Ltd. Method of inhibition of beta-secretase by using bis-o-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases
JP2017533970A (ja) 2014-11-11 2017-11-16 ヴァーデュア サイエンスィズ 加齢性疾患に対する脂溶性化合物の改善されたバイオアベイラビリティーに対する安定な固体脂質粒子組成物
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
US10639285B2 (en) 2014-12-15 2020-05-05 Aurea Biolabs Private Limited Process for preparation of bioavailable white curcumin—a unique blend of hydrogenated curcuminoids
EP3381451B1 (en) 2015-08-28 2025-08-20 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
US20170071901A1 (en) * 2015-09-15 2017-03-16 Guodong Zhang Methods and formulations for increasing chemical stability and biological activity of phenolic compounds
WO2017095138A1 (en) * 2015-11-30 2017-06-08 Gil Medical Center Curcumin-containing lipid nanoparticle complex comprising ginsenosides
WO2017189424A2 (en) 2016-04-27 2017-11-02 Signpath Pharma, Inc. Prevention of drug-induced atrio-ventricular block
US10076552B2 (en) 2016-08-09 2018-09-18 DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
EP3505168A1 (en) * 2016-08-26 2019-07-03 Caliway Biopharmaceuticals Co., Ltd. Subcutaneous injection for reducing body weight and application thereof
EP3290026A1 (en) 2016-09-06 2018-03-07 Athenion AG Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof
EP3536332A1 (en) 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
CN112839668A (zh) 2018-10-23 2021-05-25 斯达必康生命科学私人有限公司 包含非姜黄素和姜黄素的水溶性颗粒的制剂
CN109549924B (zh) * 2018-11-21 2021-05-11 四川大学华西医院 Sklb023混合胶束及其制备方法和用途
US20220151945A1 (en) * 2018-11-26 2022-05-19 Registrar, Panjab University Chandigarh Solid lipid nanoparticles of curcumin
JP2022520778A (ja) 2019-02-11 2022-04-01 ハルステッド，ヨセフ 治療目的で投与可能な高用量非水クルクミノイド溶液
WO2020214600A1 (en) * 2019-04-14 2020-10-22 The Regents Of The University Of California A sensitive lc-ms assay to measure curcuminoids in complex biological samples
WO2021111312A1 (en) * 2019-12-03 2021-06-10 Omniactive Health Technologies Limited Curcumin compositions for osteoarthritis and joint wellness
CN111388676A (zh) * 2020-02-11 2020-07-10 湖南中茂生物科技有限公司 一种提高姜黄素水溶性的组合物及其在制备治疗老年痴呆的复方中的应用
US12390504B2 (en) * 2020-03-26 2025-08-19 Verdure Sciences, Inc. Polyphenol blend of curcumin extract and pomegranate extract and methods of improving immune response
CN111568882A (zh) * 2020-06-09 2020-08-25 复旦大学附属中山医院青浦分院 一种复方姜黄素纳米粒和制备方法及其应用
US12208067B2 (en) 2020-06-26 2025-01-28 Pharmako Biotechnologies Pty Ltd. Liquid dispersible curcuminoid compositions and methods of improving cognitive function
CN112315953B (zh) * 2020-11-06 2023-03-07 中国海洋大学 一种姜黄素酯在改善急性肾损伤制品中的应用
US20230390222A1 (en) * 2021-02-01 2023-12-07 The Board Of Trustees Of The Leland Stanford Junior University Amyloid-Binding Peptoids with Broad-Spectrum Antiviral, Antibacterial, and Antifungal Activity
US20230190937A1 (en) * 2021-11-05 2023-06-22 Cornell University Iron complexes of esterified derivatives of natural products, and methods of use
EP4186497A1 (en) 2021-11-26 2023-05-31 Dorian Bevec Alpha lipoic acid, epigallocatechin 3-gallate, and curcumin as a medicament for the treatment of arthritis or sars-cov-2 infection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263333A (en) * 1979-09-12 1981-04-21 General Foods Corporation Curcumin-metal color complexes
KR920004818B1 (ko) * 1989-11-28 1992-06-18 태평양화학 주식회사 세포 보호제 조성물
US6979441B2 (en) * 1998-09-16 2005-12-27 Wilson T Crandall Method for topical treatment of carpal tunnel syndrome
US20040266883A1 (en) * 1999-10-27 2004-12-30 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
JP4179494B2 (ja) * 2001-10-23 2008-11-12 株式会社カネカ ペルオキシソーム増殖剤応答性受容体リガンド剤
US20050222250A1 (en) * 2002-04-16 2005-10-06 Mohiaddin Rezvani Curcumin for the prevention and/or treatment of tissue damage
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
WO2004031122A1 (de) * 2002-10-01 2004-04-15 Dr. André Rieks - Labor Für Enzymtechnologie Gmbh Neue curcumin/tetrahydrocurcumin-derivate für den einsatz in kosmetika, pharmazeutika und bei der ernährung
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
WO2004080396A2 (en) * 2003-03-07 2004-09-23 The University Of Texas Md Anderson Cancer Center Liposomal curcumin for treatment of cancer
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US20060045928A1 (en) * 2004-08-31 2006-03-02 Seiri Oshiro Composition containing herbal medicine component for promoting absorption and production method thereof
US20060228403A1 (en) * 2005-04-12 2006-10-12 Zimmerman Karl A Nutritional supplements for cardiovascular health
EP1837030A1 (en) * 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability

Also Published As

Publication number Publication date
EP1993365A2 (en) 2008-11-26
US9192644B2 (en) 2015-11-24
ES2427216T3 (es) 2013-10-29
US20090324703A1 (en) 2009-12-31
EP1993365A4 (en) 2010-04-07
EP1993365B1 (en) 2013-05-08
WO2007103435A3 (en) 2007-10-25
WO2007103435A2 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
PL1993365T3 (pl) Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem
EP2091566A4 (en) COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
IL264736B (en) Pharmaceutical preparations containing zonisamide for use in the treatment of diseases related to Alzheimer's disease
EP2151435A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ZA201002751B (en) Compositions for treating parkinson's disease
EP2382176A4 (en) USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL194789A0 (en) Terphenyl derivatives for treatment of alzheimer's disease
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
SG10201606441SA (en) Improved modalities for the treatment of degenerative diseases of the retina
PL2197883T3 (pl) Pochodna katecholaminy użyteczna do leczenia choroby Parkinsona
IL208926A0 (en) Use of epothelone d in treating tau-associated diseases including alzheimer's disease
EP1809601A4 (en) COMPOUNDS FOR ALZHEIMER'S DISEASE
EP2306824A4 (en) IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
EP2010215A4 (en) METHOD AND COMPOSITIONS FOR TREATING MORBUS CROHN
EP2214488A4 (en) COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
HU0500145D0 (en) Composition for the treatment of oral diseases
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
EP1863510A4 (en) METHOD FOR TREATING PARKINSON DISEASE
TWI341204B (en) Composition and method for prevention and treatment of alzheimer's disease
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases